Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Accounts Payables (2016 - 2026)

Cryo Cell International's Accounts Payables history spans 17 years, with the latest figure at $3.3 million for Q1 2026.

  • Quarterly results put Accounts Payables at $3.3 million for Q1 2026, up 20.3% from a year ago — trailing twelve months through Feb 2026 was $3.3 million (up 20.3% YoY), and the annual figure for FY2025 was $2.9 million, up 52.52%.
  • Accounts Payables for Q1 2026 was $3.3 million at Cryo Cell International, up from $2.9 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.1 million in Q2 2023 to a low of $491920.0 in Q4 2023.
  • The 5-year median for Accounts Payables is $2.2 million (2025), against an average of $2.3 million.
  • The sharpest move saw Accounts Payables tumbled 69.36% in 2023, then surged 282.64% in 2024.
  • Year by year, Accounts Payables stood at $1.6 million in 2022, then tumbled by 69.36% to $491920.0 in 2023, then surged by 282.64% to $1.9 million in 2024, then skyrocketed by 52.52% to $2.9 million in 2025, then grew by 15.0% to $3.3 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $3.3 million, $2.9 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.